Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beatriz E Marciano

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 4, 2021
Safety and Efficacy of Ustekinumab in the Inflammatory Bowel Disease of Chronic Granulomatous DiseaseSumona Bhattacharya, Beatriz E Marciano, Harry L Malech, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 10, 2004
Long-term interferon-gamma therapy for patients with chronic granulomatous diseaseBeatriz E Marciano, Robert Wesley, Ellen S De Carlo, et al.
Journal of Clinical Immunology|September 13, 2020
Nocardiosis Associated with Primary Immunodeficiencies (Nocar-DIP): an International Retrospective Study and Literature ReviewEmmanuel Lafont, Beatriz E Marciano, Nizar Mahlaoui, et al.
Pediatrics|August 3, 2004
Gastrointestinal involvement in chronic granulomatous diseaseBeatriz E Marciano, Sergio D Rosenzweig, David E Kleiner, et al.
Open Forum Infectious Diseases|December 7, 2019
Patients with Idiopathic Pulmonary Nontuberculous Mycobacterial Disease Have Normal Th1/Th2 Cytokine Responses but Diminished Th17 Cytokine and Enhanced Granulocyte-Macrophage Colony-Stimulating Factor ProductionUn-In Wu, Kenneth N Olivier, Douglas B Kuhns, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 14, 2011
Corticosteroid therapy for liver abscess in chronic granulomatous diseaseJennifer W Leiding, Alexandra F Freeman, Beatriz E Marciano, et al.
Scientific Reports|May 21, 2020
A Panoply of Rheumatological Manifestations in Patients with GATA2 DeficiencyAbhimanyu A Amarnani, Katlin R Poladian, Beatriz E Marciano, et al.
Inflammatory Bowel Diseases|November 19, 2016
Genetic Risk for Inflammatory Bowel Disease Is a Determinant of Crohn's Disease Development in Chronic Granulomatous DiseaseChengrui Huang, Suk See De Ravin, Adam R Paul, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 16, 2023
Gastrointestinal and Hepatic Manifestations of Chronic Granulomatous DiseaseAlexander H Yang, Brigit Sullivan, Christa S Zerbe, et al.
Clinical Immunology (Orlando, Fla.)|June 19, 2013
B-cell activating factor (BAFF) is elevated in chronic granulomatous diseaseKabir Matharu, Kol A Zarember, Beatriz E Marciano, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 4, 2021
Safety and Efficacy of Ustekinumab in the Inflammatory Bowel Disease of Chronic Granulomatous DiseaseSumona Bhattacharya, Beatriz E Marciano, Harry L Malech, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 10, 2004
Long-term interferon-gamma therapy for patients with chronic granulomatous diseaseBeatriz E Marciano, Robert Wesley, Ellen S De Carlo, et al.
Journal of Clinical Immunology|September 13, 2020
Nocardiosis Associated with Primary Immunodeficiencies (Nocar-DIP): an International Retrospective Study and Literature ReviewEmmanuel Lafont, Beatriz E Marciano, Nizar Mahlaoui, et al.
Pediatrics|August 3, 2004
Gastrointestinal involvement in chronic granulomatous diseaseBeatriz E Marciano, Sergio D Rosenzweig, David E Kleiner, et al.
Open Forum Infectious Diseases|December 7, 2019
Patients with Idiopathic Pulmonary Nontuberculous Mycobacterial Disease Have Normal Th1/Th2 Cytokine Responses but Diminished Th17 Cytokine and Enhanced Granulocyte-Macrophage Colony-Stimulating Factor ProductionUn-In Wu, Kenneth N Olivier, Douglas B Kuhns, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 14, 2011
Corticosteroid therapy for liver abscess in chronic granulomatous diseaseJennifer W Leiding, Alexandra F Freeman, Beatriz E Marciano, et al.
Scientific Reports|May 21, 2020
A Panoply of Rheumatological Manifestations in Patients with GATA2 DeficiencyAbhimanyu A Amarnani, Katlin R Poladian, Beatriz E Marciano, et al.
Inflammatory Bowel Diseases|November 19, 2016
Genetic Risk for Inflammatory Bowel Disease Is a Determinant of Crohn's Disease Development in Chronic Granulomatous DiseaseChengrui Huang, Suk See De Ravin, Adam R Paul, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 16, 2023
Gastrointestinal and Hepatic Manifestations of Chronic Granulomatous DiseaseAlexander H Yang, Brigit Sullivan, Christa S Zerbe, et al.
Clinical Immunology (Orlando, Fla.)|June 19, 2013
B-cell activating factor (BAFF) is elevated in chronic granulomatous diseaseKabir Matharu, Kol A Zarember, Beatriz E Marciano, et al.
Pageof 4